DAC--I also like the fact that the ceo owns 1 million, 23 thousand shares, and I know he is not interested in selling.
To post 414, Lawrence J. Vocke, my guess is they needed a tax loss, or, more likely, got a bunch of margin calls, ala Long Term Capital.
Either way, the overhead resistance is gone, and I really don't care about their reason for selling, just glad Biopool got them back, most likely on very good terms.
I also called the bottom in post 408, so now I'll call the rise.
Looking for mid $4's, on FDA approvals, which are in the pipeline. |
